Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

Automation performance depends on signal quality. Learn how Google Ads prioritizes signals, how pollution starts, and how to ...

NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis, today announced the ...

Q1 2026 earnings call highlights: record orders, margin expansion, raised EPS guidance to $4.70, and data center momentum.

Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript February 5, 2026 Exponent, Inc. beats earnings expectations.

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...

A trial focused on whether Meta misrepresented the safety of its platforms when it comes to the dangers of child sexual ...

Experts say live sports consistently dominates short-term reach on OTT platforms, followed by mass-appeal general ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced another major independent validation of its AI and machine learning (ML) capabilities in a ...

Johnson Controls International plc (NYSE:JCI) Q1 2026 Earnings Call Transcript February 4, 2026 Johnson Controls ...